CNS Metastases Terminated Phase 1 Trials for Afatinib (DB08916)

Also known as: Metastases, CNS / Metastases to central nervous system / Central Nervous System (CNS) Metastases / Central Nervous System Metastases / Metastases of Central Nervous System / Metastatic malignant neoplasm to central nervous system (disorder) / CNS metastases (tumor staging)

IndicationStatusPhase
DBCOND0050898 (CNS Metastases)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03711422Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLCTreatment